CareFusion (NYSE:CFN)

CAPS Rating: 5 out of 5

The company offers clinical and medical products for infusion, surgical procedures, medical diagnostics, medication and supply dispensing, infection prevention, and respiratory care.

Recs

1
Player Avatar htownjester (82.05) Submitted: 10/13/2009 2:08:08 AM : Outperform Start Price: $22.97 CFN Score: +65.20

Recent spinoff of CAH. CAH retains 20% of stock and must sell within 5 years- only one reason for them to retain- they think it is offers a very attractive rate of return over that time period. Insider buys and significant insider incentive through RSUs / stock plan for employees. CFN of course also stands to benefit from a very nice pop once the healthcare debate is wrapped up in Washington, and substantively CFN probably has a number of offers which actually can/will reduce the cost of healthcare in this country over the long term.

Featured Broker Partners


Advertisement